Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

YM BioSciences cleared to begin pivotal trial of tesmilifene

Nov. 6, 2003

Ark Therapeutics granted patent for EG-009

Nov. 6, 2003

Novartis scientists identify new steryl-sulfatase inhibitors

Nov. 6, 2003

New KDR/Tie-2 kinase inhibitors in early development at Abbott

Nov. 6, 2003

Merck subsidiary seeks approval for Erbitux in Australia

Nov. 5, 2003

Merck presents new KSP inhibitors with utility in cancer therapy

Nov. 5, 2003

Potent Tie-2 inhibitors discovered to be effective in models of angiogenesis

Nov. 4, 2003

Clinical trial evaluates CC-8490 for brain cancer

Nov. 4, 2003

Tissue-selective ERalpha antagonists prepared and tested at Schering AG

Nov. 4, 2003

Collaboration to test MVA-BN with HER-2 DNA AutoVac vaccine

Nov. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.